Understanding Gadolinium-Based Contrast Agents: A Primer for Health-System Pharmacists
This activity is supported by an educational grant from Guerbet LLC.
Emanuel Kanal, MD, FACR, FISMRM, AANG
Director, Magnetic Resonance Services
Professor of Radiology and
Department of Radiology
University of Pittsburgh Medical Center
At the conclusion of this educational activity, participants should be able to:
- Explain the clinical benefit of neuroradiologic gadolinium-based contrast agents (GBCAs), and the differences among available products
- Recall the relationship between GBCAs and nephrogenic systemic fibrosis (NSF)
- Recognize differences among the FDA-approved neuroradiologic GBCAs and their NSF—related risks
- Recognize late-breaking concerns regarding the safety of GBCAs
Type of activity:
January 6, 2015
January 6, 2017
Estimated time to complete activity:
This lesson is offered free at www.pharmacytimes.org
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
This activity is approved for 2.0 contact hours (0.20 CEUs) under the ACPE universal activity number 0290-0000-15-113-H04-P. The activity is available for CE credit through January 6, 2017.